Aurealis Pharma
Manufacturing · Finland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Microkatu 1, Kuopio, Northern Savo, 7021...Phone Number
+358 458433550Website
www.aurealispharma.comRevenue
$6.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Aurealis Pharma
Aurealis Therapeutics specializes in developing multi-target cell and gene therapies aimed at addressing unmet medical needs, particularly for chronic wounds, cancer, and inflammatory diseases. Their innovative platform focuses on treating complex multi-factorial diseases, including diabetic foot ulcers and various cancers. The company is dedicated to advancing scientific research to improve patient outcomes through evidence-based therapies. With a commitment to scalable and cost-effective solutions, Aurealis Therapeutics is positioned to make significant contributions to the fields of regenerative medicine and oncology.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aurealis Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Aurealis Pharma has recently received funding, and reach out quickly before it becomes old news!
Check out if Aurealis Pharma is spiking on competitors!
Product Launch: Get notified when Aurealis Pharma launches new products
Earning: See what the market has to say on Aurealis Pharma recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Aurealis Pharma has new funding data
Aurealis Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Aurealis Pharma
Click to see if Aurealis Pharma had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Aurealis Pharma
Compare insights from companies similar to Aurealis Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aurealis Pharma
$6.2M
11-50
Private
$10.8M
2010
N/A
Company Profile Activity
Activity Insights
Aurealis Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aurealis Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aurealis Pharma.
Aurealis Pharma financials insights
Gather financial insights about Aurealis Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Angel/Seed
$1.8M
2016
Angel/Seed
$3.3M
2017
Series A
$5.8M
Aurealis Pharma Tech Stack
A closer look at the technologies used by Aurealis Pharma
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aurealis Pharma
Sign Up For FreeTo access detailed company insights
Aurealis Therapeutics specializes in developing multi-target cell and gene therapies aimed at addressing unmet medical needs, particularly for chronic wounds, cancer, and inflammatory diseases. Their innovative platform focuses on treating complex multi-factorial diseases, including diabetic foot ulcers and various cancers. The company is dedicated... Read More
